The Food and Drug Administration, as part of a sweeping overhaul in how it regulates opioid painkillers, plans to look to some unusual allies to limit the flood of the addictive pills -- health insurers and companies that manage prescription drug benefits.
Trending:
Trump's FDA chief takes wide aim at opioid addiction crisis